C2CD2 inhibitors are a class of chemical compounds that target and inhibit the activity of the C2CD2 protein, which is involved in cellular processes related to membrane dynamics and intracellular signaling. C2CD2 is a member of the C2 domain-containing protein family, which is characterized by its ability to bind to phospholipids in a calcium-dependent manner. This protein is thought to play roles in processes such as vesicle trafficking, membrane repair, and signal transduction. C2CD2 inhibitors are designed to interfere with these functions by binding to specific regions of the protein, particularly the C2 domain, which is responsible for its interaction with membrane lipids and other proteins. By blocking these interactions, the inhibitors disrupt the normal activity of C2CD2, allowing researchers to explore its functional significance in various cellular processes.
The development of C2CD2 inhibitors involves structural studies of the protein to identify critical interaction sites. These inhibitors are often small molecules or peptides that exhibit high specificity for the C2CD2 protein, preventing it from engaging in its normal cellular roles. Such specificity is crucial in avoiding off-target effects that could interfere with other C2 domain-containing proteins. Through these inhibitors, scientists can investigate how C2CD2 contributes to processes like vesicle formation, intracellular signaling, and membrane dynamics, providing insights into the broader role of C2 domain-containing proteins in cell biology. C2CD2 inhibitors are valuable tools for dissecting the molecular mechanisms by which C2CD2 participates in cellular communication and structural maintenance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could reduce C2CD2 expression by reversing methylation on the gene's promoter, leading to transcriptional repression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By inhibiting DNA methyltransferases, 5-Aza-2′-Deoxycytidine may decrease methylation levels on the C2CD2 promoter, contributing to a downregulation of its transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid could lead to increased acetylation of histones near the C2CD2 gene, potentially disrupting binding of transcriptional repressors and decreasing C2CD2 expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Similar to vorinostat, MS-275 could downregulate C2CD2 expression by altering chromatin accessibility and hindering the binding of transcriptional machinery. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could reduce C2CD2 expression by inhibiting the mTOR pathway, which is involved in controlling protein synthesis at the translational level. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
As an intercalating agent, chloroquine might decrease C2CD2 mRNA synthesis by blocking nucleic acid replication and transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to DNA, Mithramycin A could inhibit the transcription initiation complex formation on the C2CD2 gene, leading to a decrease in its expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may downregulate C2CD2 by inhibiting the activity of RNA polymerase II, thereby reducing transcription of the C2CD2 gene. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin could decrease C2CD2 expression by inhibiting kinases involved in the signaling pathways that control transcriptional activation of the gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could downregulate C2CD2 expression by activating retinoic acid receptors that repress transcription of specific target genes. | ||||||